A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis - PubMed (original) (raw)
Comparative Study
doi: 10.1038/ng1268. Epub 2003 Nov 9.
Li Cao, James G Krueger, Ellen M Wijsman, Francesca Chamian, Derek Gordon, Michael Heffernan, Jil A Wright Daw, Jason Robarge, Jurg Ott, Pui-Yan Kwok, Alan Menter, Anne M Bowcock
Affiliations
- PMID: 14608357
- DOI: 10.1038/ng1268
Comparative Study
A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis
Cynthia Helms et al. Nat Genet. 2003 Dec.
Abstract
Psoriasis (OMIM 177900) is a chronic inflammatory skin disorder of unknown pathogenesis affecting approximately 2% of the Western population. It occurs more frequently in individuals with human immunodeficiency virus, and 20-30% of individuals with psoriasis have psoriatic arthritis. Psoriasis is associated with HLA class I alleles, and previous linkage analysis by our group identified a second psoriasis locus at 17q24-q25 (PSORS2; ref. 7). Linkage to this locus was confirmed with independent family sets. Additional loci have also been proposed to be associated with psoriasis. Here we describe two peaks of strong association with psoriasis on chromosome 17q25 separated by 6 Mb. Associated single-nucleotide polymorphisms (SNPs) in the proximal peak lie in or near SLC9A3R1 (also called EBP50 and NHERF1) and NAT9, a new member of the N-acetyltransferase family. SLC9A3R1 is a PDZ domain-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family and is implicated in diverse aspects of epithelial membrane biology and immune synapse formation in T cells. The distal peak of association is in RAPTOR (p150 target of rapamycin (TOR)-scaffold protein containing WD-repeats). Expression of SLC9A3R1 is highest in the uppermost stratum Malpighi of psoriatic and normal skin and in inactive versus active T cells. A disease-associated SNP lying between SLC9A3R1 and NAT9 leads to loss of RUNX1 binding. This is the second example of loss of a RUNX1 binding site associated with susceptibility to an autoimmune disease. It also suggests defective regulation of SLC9A3R1 or NAT9 by RUNX1 as a susceptibility factor for psoriasis.
Comment in
- A RUNX trio with a taste for autoimmunity.
Alarcón-Riquelme ME. Alarcón-Riquelme ME. Nat Genet. 2003 Dec;35(4):299-300. doi: 10.1038/ng1203-299. Nat Genet. 2003. PMID: 14647282 No abstract available. - No association between atopic dermatitis and the SLC9A3R1-NAT9 RUNX1 binding site polymorphism in Japanese patients.
Hosomi N, Fukai K, Oiso N, Kato A, Fukui M, Ishii M. Hosomi N, et al. Clin Exp Dermatol. 2005 Mar;30(2):192-3. doi: 10.1111/j.1365-2230.2005.01720.x. Clin Exp Dermatol. 2005. PMID: 15725257 No abstract available.
Similar articles
- An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis.
Tokuhiro S, Yamada R, Chang X, Suzuki A, Kochi Y, Sawada T, Suzuki M, Nagasaki M, Ohtsuki M, Ono M, Furukawa H, Nagashima M, Yoshino S, Mabuchi A, Sekine A, Saito S, Takahashi A, Tsunoda T, Nakamura Y, Yamamoto K. Tokuhiro S, et al. Nat Genet. 2003 Dec;35(4):341-8. doi: 10.1038/ng1267. Epub 2003 Nov 9. Nat Genet. 2003. PMID: 14608356 - Investigation of association of genes NAT9, SLC9A3R1 and RAPTOR on chromosome 17q25 with psoriatic arthritis.
Filer CE, Ho P, Bruce IN, Worthington J, Barton A. Filer CE, et al. Ann Rheum Dis. 2009 Feb;68(2):292-3. doi: 10.1136/ard.2008.087965. Ann Rheum Dis. 2009. PMID: 19139211 No abstract available. - Genetic polymorphisms of the HCR gene and a genomic segment in close proximity to HLA-C are associated with patients with psoriasis in Taiwan.
Chang YT, Shiao YM, Chin PJ, Liu YL, Chou FC, Wu S, Lin YF, Li LH, Lin MW, Liu HN, Tsai SF. Chang YT, et al. Br J Dermatol. 2004 Jun;150(6):1104-11. doi: 10.1111/j.1365-2133.2004.05972.x. Br J Dermatol. 2004. PMID: 15214895 - The genetics of psoriasis, psoriatic arthritis and atopic dermatitis.
Bowcock AM, Cookson WO. Bowcock AM, et al. Hum Mol Genet. 2004 Apr 1;13 Spec No 1:R43-55. doi: 10.1093/hmg/ddh094. Hum Mol Genet. 2004. PMID: 14996755 Review. - The genetic basis of psoriasis.
Valdimarsson H. Valdimarsson H. Clin Dermatol. 2007 Nov-Dec;25(6):563-7. doi: 10.1016/j.clindermatol.2007.08.010. Clin Dermatol. 2007. PMID: 18021893 Review.
Cited by
- Decoding the Immune Response and Its Biomarker B2M for High Altitude Pulmonary Edema in Rat: Implications for Diagnosis and Prognosis.
Yuan M, Wan W, Xing W, Pu C, Wu X, Liao Z, Zhu X, Hu X, Li Z, Zhao Q, Zhao H, Xu X. Yuan M, et al. J Inflamm Res. 2024 Oct 11;17:7195-7217. doi: 10.2147/JIR.S477633. eCollection 2024. J Inflamm Res. 2024. PMID: 39411751 Free PMC article. - Dysregulation of the Skin-Liver Axis in Prurigo Nodularis: An Integrated Genomic, Transcriptomic, and Population-Based Analysis.
Marani M, Madan V, Le TK, Deng J, Lee KK, Ma EZ, Kwatra SG. Marani M, et al. Genes (Basel). 2024 Jan 23;15(2):146. doi: 10.3390/genes15020146. Genes (Basel). 2024. PMID: 38397136 Free PMC article. - Molecular consideration relevant to the mechanism of the comorbidity between psoriasis and systemic lupus erythematosus (Review).
Qu Y, Li D, Liu W, Shi D. Qu Y, et al. Exp Ther Med. 2023 Aug 29;26(4):482. doi: 10.3892/etm.2023.12181. eCollection 2023 Oct. Exp Ther Med. 2023. PMID: 37745036 Free PMC article. Review. - Natural history study of patients with familial platelet disorder with associated myeloid malignancy.
Cunningham L, Merguerian M, Calvo KR, Davis J, Deuitch NT, Dulau-Florea A, Patel N, Yu K, Sacco K, Bhattacharya S, Passi M, Ozkaya N, De Leon S, Chong S, Craft K, Diemer J, Bresciani E, O'Brien K, Andrews EJ, Park N, Hathaway L, Cowen EW, Heller T, Ryan K, Barochia A, Nghiem K, Niemela J, Rosenzweig S, Young DJ, Frischmeyer-Guerrerio PA, Braylan R, Liu PP. Cunningham L, et al. Blood. 2023 Dec 21;142(25):2146-2158. doi: 10.1182/blood.2023019746. Blood. 2023. PMID: 37738626 - N-Acetyltransferase 9 ameliorates Aβ42-mediated neurodegeneration in the Drosophila eye.
Deshpande P, Chimata AV, Snider E, Singh A, Kango-Singh M, Singh A. Deshpande P, et al. Cell Death Dis. 2023 Jul 28;14(7):478. doi: 10.1038/s41419-023-05973-z. Cell Death Dis. 2023. PMID: 37507384 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous